Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The consent form as a possible cause of side effects.

Myers MG, Cairns JA, Singer J.

Clin Pharmacol Ther. 1987 Sep;42(3):250-3.

PMID:
3621780
2.

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, et al.

N Engl J Med. 1985 Nov 28;313(22):1369-75.

PMID:
3903504
3.

A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.

Gent M, Barnett HJ, Sackett DL, Taylor DW.

Circulation. 1980 Dec;62(6 Pt 2):V97-105.

PMID:
7002357
4.
5.

[Controversy on platelet-inhibiting drugs].

Oelz O.

Schweiz Med Wochenschr. 1985 May 18;115(20):703-7. Review. German.

PMID:
3892659
7.

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.

Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, Touboul PJ.

Stroke. 1983 Jan-Feb;14(1):5-14.

8.

Antiplatelet therapy in the prevention of ischaemic stroke.

Verry M, Panak E, Cazenave JP.

Nouv Rev Fr Hematol. 1994 Jun;36(3):213-28. Review.

PMID:
7971242
9.

[The platelet inhibitor problem].

Straub PW.

Schweiz Med Wochenschr. 1981 Apr 4;111(14):478-82. German.

PMID:
7015489
10.

[Informed consent, what information is left after a therapeutic trial?].

Gallet M, Aupetit JF, Servan E, Lestaevel M, Lopez M, Chassoux G.

Arch Mal Coeur Vaiss. 1994 Jan;87(1):39-45. French.

PMID:
7811150
11.

Clinical aspects of antiplatelet therapy.

Sherry S.

Semin Hematol. 1985 Apr;22(2):125-34. Review. No abstract available.

PMID:
3890191
12.

A randomized trial of aspirin and sulfinpyrazone in patients with TIA.

Candelise L, Landi G, Perrone P, Bracchi M, Brambilla G.

Stroke. 1982 Mar-Apr;13(2):175-9.

13.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
14.

Unstable angina: status of aspirin and other forms of therapy.

Lewis HD Jr.

Circulation. 1985 Dec;72(6 Pt 2):V155-60.

PMID:
3905054
15.

Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.

Khuroo MS, Khuroo MS, Farahat KL, Kagevi IE.

J Gastroenterol Hepatol. 2005 Jan;20(1):11-25. Review.

PMID:
15610441
16.

Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.

Serebruany VL, Midei MG, Meilman H, Malinin AI, Lowry DR.

Int J Clin Pract. 2006 Jul;60(7):863-6.

PMID:
16846403
17.

Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy.

Weiner DA, McCabe CH, Cutler SS, Creager MA, Ryan TJ, Klein MD.

Am J Cardiol. 1983 May 1;51(8):1251-5.

PMID:
6342351
18.
19.

Randomized trial of therapy with platelet antiaggregants for threatened stroke.

[No authors listed]

Can Med Assoc J. 1980 Feb 9;122(3):293-6. No abstract available.

20.

Prognosis of patients with stable angina pectoris on antianginal drug therapy.

Hjemdahl P, Eriksson SV, Held C, Rehnqvist N.

Am J Cardiol. 1996 Jun 20;77(16):6D-15D. Review.

PMID:
8677897
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk